The document this correction applies to
Timely disclosureWhat was corrected and how
A subsequent correction by the company to the contents of an already published filing.
Notice of Obtaining Marketing Approval for ドロエチフレックス® Combination Product “Asuka”
Open the original documentTitle, body, summary title and marketing name
Droechiflex Combination Tablets® “ASKA”
ドロエチフレックス® Combination Tablet “Asuka”
Because certain information required correction
| Item | Details |
|---|---|
| Disclosure subject to correction | Notice of Obtaining Marketing Approval for ドロエチフレックス® Combination Product “Asuka” |
| Original disclosure date | 17 August 2026 |
| Location of correction | Title, body, summary title and marketing name |
| Details of correction | Droechiflex Combination Tablets® “ASKA” → ドロエチフレックス® Combination Tablet “Asuka” |
| Reason for correction | Because certain information required correction |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The disclosure published on 17 August 2026 contained information requiring correction. No specific cause was stated.